United Kingdom news - the latest biotech news from Labiotech.eu

Home United Kingdom Page 54

Latest Posts

Screenshot 2017 01 23 at 3.58.16 PM 1 e1485183691824

News and Trends 23 Jan 2017

New Fundraising Boosts Ultra-Rapid STD Detection

Atlas Genetics has raised €32.6M in Series D. The funds will help the company bring ultra-rapid diagnostic tests for STDs to the market. Atlas Genetics, a spin-off from the University of Bath, has closed an impressive €32.6M ($35M) Series D round of fundraising. The funds will support clinical trials, manufacturing and the commercial launch of the company’s second ultra-rapid […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

MarkLowdell2

Interview 23 Jan 2017

“Senior Staff Snobbery separates Academia from the Biotech Industry”

We caught up with Mark Lowdell, Director of Cellular Therapeutics and the RFH/UCL Cancer Biobank. As one of the few successful scientist-entrepreneurs, he has some ideas about bridging academia and industry in biomedicine. Mark Lowdell was introduced to me by his business partner, RJ Tesi. Tesi co-founded INmune Bio, a promising California-based startup, on Lowdell’s […]

January 23, 2017 - 6 minutesmins - By Evelyn Warner

shutterstock 527246122

News and Trends 16 Jan 2017

The UK Steps Up its Game in Automated CRISPR Gene Editing

Horizon Discovery now has full access to CRISPR technology and will develop an automated gene editing platform in collaboration with Solentim. Horizon Discovery, based in Cambridge, UK, uses gene editing technology to create custom cell lines for research. To step up its game, the company has upgraded its existing license with ERS Genomics‘ to obtain […]

January 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

heirloom

More News! 14 Jan 2017

This Bioartist is Exhibiting Living Portraits of her own Daughters

Gina Czarnecki raises questions about identity and ownership of our own bodies through living artwork that once used to form part of other human beings. Gina Czarnecki, based in London, has used her own daughters’ cells to create unique pieces of art. In her project ‘Heirloom‘, recently exhibited at Medical Museion Copenhagen and created in collaboration […]

January 14, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Screenshot 2017 01 12 at 6.46.14 PM 1 e1484300509836

Startup Scout 13 Jan 2017

The Good, the Bad and the Cancer-Fighting Macrophage

We decided to stick around England this week and made a short trip from London to visit the young biotech Macrophage Pharma. The company is developing immuno-oncology technology that could turn ‘bad’ tumor-associated macrophages into ‘good’, cancer-fighting cells. City: Berkhamsted, UK (near London) Founded: 2014 Employees: 1-10 Financial data: €10.38M total raised Mission: Macrophage Pharma develops next-generation immunotherapies […]

January 13, 2017 - 1 minutemin - By Clara Rodríguez Fernández

agriculture biotech rna spray bioclay

News and Trends 13 Jan 2017

RNA Spray fights Viruses and could Sidestep problems with GMOs

RNA and clay could be the future of crop protection and manipulation of plants’ traits. Researchers have managed to use these ingredients to create a spray capable of “vaccinating” plants, teaching them to recognize the genetic material of viruses. RNA-based therapies may have suffered a recent blow in the clinic this week, but when it comes […]

January 13, 2017 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

shutterstock 510121324

News and Trends 10 Jan 2017

Stem Cells in your Teeth can be Stimulated to Naturally Repair Cavities

Researchers from the UK have described a new treatment for cavities that could get rid of fillings and cements by employing an Alzheimer’s drug. Most of us have visited the dentist to fill a cavity. The usual procedure involves removing the damaged area and replacing it with mineral materials. But what if you could let […]

January 10, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

download 2 e1483969269550

More News! 7 Jan 2017

Bacon Jewelry and Tissue Engineered Bio Fashion from the Future

Biodesigner Amy Congdon envisions a future where biotechnology is essential in all aspects of our lives, from regenerating organs to fashion. Amy Congdon is a designer based in London that uses her art to explore the implications of biotech. In particular, most of her work revolves around the intersection of two fields that might seem utterly unrelated: […]

January 7, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

crispr platform protocol desktop genetics

News and Trends 6 Jan 2017

‘Packaged’ CRISPR Systems to Standardize novel Biomedical Research

There’s a growing appetite to refine and standardize CRISPR protocols, as its application expands into different areas of genomic research. The Wellcome Trust and Desktop Genomics have recent advances to make it more efficient and controllable. Outside of the high-stakes world of therapeutic CRISPR, which has enjoyed gambling-like investment and whose legal future is unfolding in court, this […]

January 6, 2017 - 3 minutesmins - By Denise Neves Gameiro

shutterstock 546384331

More News! 5 Jan 2017

Investors Jump on Hypersensitivity Peptides from GSK Spinout

Neurokinins are under investigation for a range of conditions from women’s health to pain. NeRRe gets a boost for its programs. Neurotransmitting peptides just got a cash injection from Forbion, Fountain Healthcare Partners, Advent Life Sciences, Novo A/S, and Orbimed. NeRRe Therapeutics, a UK-based spinout of GSK, nailed down a €27M (£23M) Series B round. Helmed by […]

January 5, 2017 - 2 minutesmins - By Evelyn Warner

shutterstock 546227944

News and Trends 4 Jan 2017

This British Biotech is buying its way into the Crowded NASH Space

Tiziana Life Sciences is acquiring candidates to gain leverage in the profitable NASH market, where there’s currently a fierce competition. Tiziana Life Sciences, a biopharmaceutical company from London, is planning to enter the competitive space of non-alcoholic steatohepatitis (NASH). To gain leverage over bigger companies fighting to enter a market expected to hit a massive €38B ($40B) by […]

January 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 537940168

News and Trends 22 Dec 2016

BMS Offers €850M for a British Oncolytic Virus better than CAR-T

BMS is offering PsiOxus Therapeutics a massive deal to get exclusive rights of an oncolytic virus that could outperform the promising CAR-T therapies. PsiOxus Therapeutics, based in Oxford, develops immuno-oncolytic viruses to treat solid tumors. Its technology attracted a partnership with Bristol-Myers Squibb earlier this year, which is now offering the British biotech an impressive €850M […]

December 22, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT